Relevant bibliographies by topics / Ovarian metastasis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Ovarian metastasis'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Ovarian metastasis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Ovarian metastasis"

1

Falchook, G. S., G. R. Varadhachary, and R. A. Wolff. "Retrospective review of patients with adenocarcinoma of the pancreas and ovarian metastasis: Clinical characteristics, treatment strategies, and survival data." Journal of Clinical Oncology 24, no. 18_suppl (2006): 14068. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.14068.

Full text
Abstract:
14068 Background: Ovarian metastasis from pancreatic adenocarcinoma is rare, and data on clinical features, treatment, and survival are limited. Methods: Charts of 19 patients with pancreatic adenocarcinoma and ovarian metastasis identified by the UTMDACC tumor registry from 1984–2005 were reviewed. Results: Clinical characteristics and survival data are in the Table. Data were limited in patients seen for single-visit second-opinion consultation or for whom only pathology was available. Other synchronous metastatic sites included peritoneum (11), liver (9), lung (5), fallopian tubes (4), uter
APA, Harvard, Vancouver, ISO, and other styles
2

Thornblade, Lucas W., Ernest Han, and Yuman Fong. "Colorectal cancer ovarian metastases." International Journal of Gynecologic Cancer 31, no. 8 (2021): 1137–44. http://dx.doi.org/10.1136/ijgc-2020-002328.

Full text
Abstract:
ObjectiveOvarian metastases occur in 3%–5% of patients with colorectal cancer. The role of oophorectomy in that setting continues to be debated. We aimed to assess the survival of women treated with metastasectomy for ovarian metastasis.MethodsRetrospective cohort study of patients in the California Cancer Registry (2000–2012) with stage IV colorectal cancer and ovarian metastases. Pathology other than adenocarcinoma was excluded. Adjusted Cox-proportional hazard analysis was applied to assess the risk of death.ResultsA total of 756 patients with synchronous ovarian metastases and 516 patients
APA, Harvard, Vancouver, ISO, and other styles
3

Kulal, Santhosha, Manjunath G N, and Abhay K. Kattepur. "Uninvited Guest in the H ouse: A Rare Case of Metastatic Gallbladder Cancer." JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES 13, no. 4 (2023): 133–35. http://dx.doi.org/10.58739/jcbs/v13i4.23.8.

Full text
Abstract:
Gallbladder cancer is a rare malignancy. About 1–2% of surgical specimens demonstrated a gallbladder cancer as an incidental finding. Metastasis to ovaries by biliary origin, known as Krukenberg tumour, though known, is infrequent. It can mimic clinically and morphologically, as a primary ovarian tumour challenging the diagnosis. Diagnosis of secondary ovarian tumours though its challenging often misdiagnosed as primary ovarian cancer, specifically mucinous adenocarcinomas. The distinction from the latter is essential, as it requires different treatment. Immunohistochemistry plays an important
APA, Harvard, Vancouver, ISO, and other styles
4

Yamanishi, Yukio, Masafumi Koshiyama, Megumi Ohnaka, et al. "Pathways of Metastases from Primary Organs to the Ovaries." Obstetrics and Gynecology International 2011 (2011): 1–6. http://dx.doi.org/10.1155/2011/612817.

Full text
Abstract:
To investigate the metastatic pathways from the primary organs to the ovaries, we examined the microscopic findings from 18 original and 18 metastatic ovarian tumors carefully. In addition, we examined the immunohistochemical findings (Victoria blue stain for vascular invasion and D2-40 expression for lymphangio invasion) of metastatic ovarian tumors carefully. There were 4 (57%) ovarian lymphangio invasion cases in the 7 gastric cancers, but there were no cases in the 6 colorectal cancers (P< 0.05). There were 4 (67%) ovarian vascular invasion cases and one (17%) liver metastasis case in t
APA, Harvard, Vancouver, ISO, and other styles
5

Dandapani, Monica, Brandon-Luke L. Seagle, Amer Abdullah, Bryce Hatfield, Robert Samuelson, and Shohreh Shahabi. "Metastatic Uterine Leiomyosarcoma Involving Bilateral Ovarian Stroma without Capsular Involvement Implies a Local Route of Hematogenous Dissemination." Case Reports in Obstetrics and Gynecology 2015 (2015): 1–5. http://dx.doi.org/10.1155/2015/950373.

Full text
Abstract:
Uterine sarcomas spread via lymphatic and hematogenous dissemination, direct extension, or transtubal transport. Distant metastasis often involves the lungs. Ovarian metastasis is uncommon. Here we present an unusual case of a large, high-grade uLMS with metastatic disease internal to both ovaries without capsular involvement or other abdominal diseases, and discovered in a patient with distant metastases to the lungs, suggesting likely hematogenous dissemination of uLMS to the ovaries in this case. Knowledge of usual uLMS metastases may influence surgical management in select cases.
APA, Harvard, Vancouver, ISO, and other styles
6

Gurbuz, A., G. Kir, A. Karateke, B. Haliloglu, and C. Kabaca. "Metastatic ovarian carcinoma one year after surgical removal of colon carcinoma during pregnancy: a case report." International Journal of Gynecologic Cancer 16, Suppl 1 (2006): 330–33. http://dx.doi.org/10.1136/ijgc-00009577-200602001-00057.

Full text
Abstract:
Colorectal carcinoma during pregnancy is a very rare event. We presented a woman with metachronous metastatic ovarian tumor existing 1 year after surgical removal of perforated sigmoid colon carcinoma encountered during cesarean section of woman of 36-week gestation for fetal distress. Pregnant women with suspicious abdominal mass should be evaluated for a possible colorectal carcinoma even in the absence of any other gastrointestinal symptoms associated with it and undergo rectal examination and sigmoidoscopy. In addition, as synchronous and metachronous ovarian metastases are common in these
APA, Harvard, Vancouver, ISO, and other styles
7

Pipal, Vibha Rani, Pratibha Singh, Dharmendra Kumar Pipal, and Poonam Elhence. "Skin Metastases in Ovarian Malignancy: A Case Report with Literature Review." Journal of Mid-life Health 14, no. 1 (2023): 49–52. http://dx.doi.org/10.4103/jmh.jmh_137_22.

Full text
Abstract:
ABSTRACT Ovarian cancer is the most lethal gynecologic malignancy, mostly diagnosed in the advanced stage with multiple sites of metastases. Routes of spread are direct through exfoliation, lymphatic channels, and less commonly hematogenous spread. Skin metastasis in ovarian malignancy is a rare occurence, its incidence range from 1.9% to 5.1% and the most common sites are the abdominal wall and chest wall. The incidence of metastasis to breast and/or axillary lymph nodes is very rare, ranging from 0.03% to 0.6%. We report the case of a 60-year-old female with stage IV B undifferentiated ovari
APA, Harvard, Vancouver, ISO, and other styles
8

TAY, S. K., and H. RAJESH. "Brain metastases from epithelial ovarian cancer." International Journal of Gynecologic Cancer 15, no. 5 (2005): 824–29. http://dx.doi.org/10.1136/ijgc-00009577-200509000-00018.

Full text
Abstract:
Brain metastasis from epithelial ovarian cancer is uncommon. We studied the presentation, treatment, and prognosis of brain metastasis in a single institution. A retrospective review of clinical details kept in the computer database of gynecologic oncology services in a tertiary institution between 1993 and 2003 was done. A Medline search for English publications on brain metastasis from epithelial ovarian cancer was performed from 1966 to 2003. The study period included 605 patients, and 4 (0.66%) patients developed brain metastases. The patients were usually well, until they presented with h
APA, Harvard, Vancouver, ISO, and other styles
9

Turanjanin, Dragan, Nikola Stipic, Nevena Stanulovic, and Nikola Gardic. "Risk factors for peritoneal dissemination of ovarian cancer." Medical review 76, no. 11-12 (2023): 331–37. http://dx.doi.org/10.2298/mpns2312331t.

Full text
Abstract:
Introduction. Ovarian epithelial tumors constitute 60% of all ovarian tumors and approximately 90% of primary ovarian tumors. Most patients are diagnosed at an advanced stage of the disease. Epithelial ovarian tumors typically spread via transcoelomic dissemination, with about 70% of patients presenting with peritoneal metastases. Additionally, cancers can metastasize to the pelvic lymph nodes. The objective of this study was to identify which clinical characteristics of malignant ovarian cancer might influence the occurrence of peritoneal metastases. Material and Methods. This retrospective s
APA, Harvard, Vancouver, ISO, and other styles
10

Wang, Wei, Chun-Chi Lin, Wen-Yi Liang, Shih-Ching Chang, and Jeng-Kai Jiang. "Adenocarcinoma of sigmoid colon with metastasis to an ovarian mature teratoma: A case report." World Journal of Clinical Cases 12, no. 4 (2024): 853–58. http://dx.doi.org/10.12998/wjcc.v12.i4.853.

Full text
Abstract:
BACKGROUND Colorectal cancer ranks third in global cancer-related mortality, often due to metastases to liver and lungs. Ovarian metastases are less common, accounting for 3.6% to 7.4% of cases. In contrast, mature ovarian teratomas are frequently benign. Tumor-to-tumor metastasis is a rare phenomenon, with a limited number of documented cases. Three cases of mature ovarian teratomas metastasizing from different cancers have been reported. This report focuses on a case of tumor-to-tumor metastasis from sigmoid colon adenocarcinoma to a mature ovarian teratoma. CASE SUMMARY A 41-year-old Taiwan
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Ovarian metastasis"

1

Park, Se Hyung. "Estrogen in ovarian cancer cell metastasis." Thesis, University of British Columbia, 2008. http://hdl.handle.net/2429/1287.

Full text
Abstract:
Benign ovarian tumors and majority of epithelial ovarian cancers possess steroid receptors including estrogen receptors (ERs). However, the estrogen-ER signaling in ovarian carcinomas is not completely understood. Tumorigenesis is a multiple-step process involving dysregulated cell growth and metastasis. Tumor cells acquire the capacity of migration and invasion by temporal phenotypical and genotypical changes termed epithelial-mesenchymal transition (EMT). Considerable evidence implicates a mitogenic action of estrogen in early ovarian carcinogenesis. In contrast, its influence in the metasta
APA, Harvard, Vancouver, ISO, and other styles
2

Leber, Thomas Matthias. "Regulation of MMP-9 in human ovarian cancer." Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.298185.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Huisken-Hill, Alyse Lynn. "Influencing Pathways that Cause Metastasis and Stemness in Epithelial Ovarian Cancer." CSUSB ScholarWorks, 2016. https://scholarworks.lib.csusb.edu/etd/355.

Full text
Abstract:
Ovarian cancer is the fifth leading cause of cancer death in women between the ages of 35 and 74. With 22 thousand new cases and 15 thousand deaths annually ovarian cancer is among the most deadly cancers with a death to incidence ratio of 68%. With 70% of cases High Grade Serous Ovarian Carcinoma (HGSOC) is the most common type of ovarian cancer and causes 90% of ovarian cancer deaths. 80% of patients have reoccurrence within five years and only 15-30% of patients with recurrent metastatic ovarian cancer respond to current therapies, chemotherapy and surgery. One reason for the high reoccurre
APA, Harvard, Vancouver, ISO, and other styles
4

Davidowitz, Rachel Alexis. "Mechanisms Governing Mesothelial Clearance by Ovarian Cancer Spheroids." Thesis, Harvard University, 2013. http://dissertations.umi.com/gsas.harvard:10719.

Full text
Abstract:
Metastatic dissemination of ovarian tumors involves the invasion of multi-cellular tumor cell clusters into the mesothelial cell lining of organs in the peritoneal cavity. We developed an in vitro assay that models this initial step of ovarian cancer metastasis to investigate the mechanisms of invasion. Pre-clustered ovarian cancer multicellular spheroids are incubated with GFP-expressing mesothelial monolayers and the extent of mesothelial invasion is monitored by time-lapse video microscopy.
APA, Harvard, Vancouver, ISO, and other styles
5

Gardner, M. J. "Adhesion molecules in the interactions of ovarian tumour cells and mesothelial cells." Thesis, University of Newcastle Upon Tyne, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.336754.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cheung, Wai-ting. "Role of gonadotropin-releasing hormone of metastatic potential of ovarian cancer cells." Click to view the E-thesis via HKUTO, 2009. http://sunzi.lib.hku.hk/hkuto/record/B41634184.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cohen, Courtney Alicia. "The Omental Fat Band as an Immunomodulatory Microenvironment for Ovarian Cancer." Diss., Virginia Tech, 2013. http://hdl.handle.net/10919/50968.

Full text
Abstract:
Cancer research is evolving. Historically concerned with the mechanisms by which malignant cells circumvent cell death signaling and maintain unchecked proliferation, focus has shifted to the complex interactions between the tumor cell and the surrounding microenvironment. Ovarian cancer has one of the highest incidence-to-death ratios of all cancers, and is typically asymptomatic until the later stages, often resulting in metastasis prior to discovery. Naturally occurring phenotypes like lactation and child-bearing (parity) reduce ovarian cancer incidence, but the mechanisms are not understoo
APA, Harvard, Vancouver, ISO, and other styles
8

Winiarski, Boleslaw Karol. "Cross talk between ovarian cancer cells and microvascular omental endothelial cells : potential role in metastasis of ovarian cancer to the omentum." Thesis, Exeter and Plymouth Peninsula Medical School, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.541700.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Everitt, Gemma Louise Ann. "The inflammatory infiltrate of high-grade serous carcinoma omental metastasis." Thesis, Queen Mary, University of London, 2014. http://qmro.qmul.ac.uk/xmlui/handle/123456789/8038.

Full text
Abstract:
The aim of this thesis is to investigate the role of inflammatory infiltrates and chemokines in metastasis of high-grade serous ovarian cancer, HGSC, to the omentum using human tissue biopsies and a 3- dimensional (3D) cell culture model. In ten patients with metastatic HGSC, omental tumour deposits contained a prominent leukocyte infiltrate of CD3+ T cells (9% of total cells) and CD68+ macrophages (11% of total cells). The presence of CD68+ macrophages showed a significant positive correlation with tumour cell proliferation analysed by Ki67 expression. Four ovarian cancer cell lines were co-c
APA, Harvard, Vancouver, ISO, and other styles
10

Pranjol, Md Zahidul Islam. "Regulation of angiogenic processes in omental endothelial cells during metastasis of epithelial ovarian cancer." Thesis, University of Exeter, 2017. http://hdl.handle.net/10871/29914.

Full text
Abstract:
Epithelial ovarian cancer frequently metastasizes to the omentum, a process that requires pro-angiogenic activation of local microvascular endothelial cells (ECs) by tumour-secreted factors. We have previously shown that ovarian cancer cells secrete factors, other than vascular endothelial growth factor (VEGF), with possible roles in metastatic angiogenesis including the lysosomal proteases cathepsin L (CathL) and cathepsin D (CathD), and insulin-like growth factor binding protein 7 (IGFBP7). However, the mechanisms by which these factors may contribute to omental endothelial angiogenic change
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Ovarian metastasis"

1

N, Chatzigeorgiou Konstantinos, and Bontis John N, eds. Peritoneal carcinomatosis from ovarian cancer. Nova Science Publishers, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fishman, David A., and M. Sharon Stack. Ovarian Cancer. Springer, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ovarian Cancer: Second Edition (Cancer Treatment and Research Book 149). Springer, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fishman, David A., and M. Sharon Stack. Ovarian Cancer: Second Edition. Springer, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Messmer, Michelle N., Colleen S. Netherby, and Scott I. Abrams. Unique Challenges Facing Immunotherapy of Metastatic Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0012.

Full text
Abstract:
The immune system serves as an integral checkpoint to developing malignancies. However, when cancer ultimately becomes detectable, this implicates an inherent failure of effective immune control. One constant theme in cancer biology has been the ability of these “diseases,” in particular, ovarian cancer, to compromise immune-mediated mechanisms of neoplastic control. These empirical observations have subsequently laid the scientific foundation to investigate ways in which the immune system can be reengaged as a powerful therapeutic weapon, singly or in combination with other modalities. This f
APA, Harvard, Vancouver, ISO, and other styles
6

Hodgkiss, Andrew. Psychiatric consequences of particular cancers. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198759911.003.0004.

Full text
Abstract:
Certain tumour types can cause psychopathology through direct biological mechanisms such as metastatic spread to the brain, release of onconeuronal antibodies, ectopic hormone secretion, or release of pro-inflammatory cytokines. Lung cancers, adenocarcinoma of the pancreas, brain tumours, and ovarian tumours are considered in detail. Confusional states due to brain metastases, syndrome of inappropriate ADH secretion, hypercalcaemia of malignancy, and anti-Hu encephalitis are found in lung cancers. Severe depression, due to interleukin-6 release and its actions on the HPA axis and tryptophan me
APA, Harvard, Vancouver, ISO, and other styles
7

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, and Gareth Morris-Stiff. Head and neck cancers. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199689842.003.0021.

Full text
Abstract:
Outlines the epidemiology, aetiology, pathology and metastatic patterns of the common gynaecological diseases. Includes ovarian, uterine, cervical, vulval and trophoblastic cancers. Guides to diagnosis, staging and planning therapy. Outlines surgical, radiotherapy and chemotherapy options for both early stage and metastatic disease. Highlights the common dilemmas in planning therapy in women of child bearing potential and older women with concurrent illneses.
APA, Harvard, Vancouver, ISO, and other styles
8

Ali-Fehmi, Rouba, and Eman Abdulfatah. Biological Aspects and Clinical Applications of Serum Biomarkers in Ovarian Cancer. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190248208.003.0002.

Full text
Abstract:
Ovarian cancer, the most aggressive gynecological malignancy, presents at advanced stages with metastatic disease. Diagnosis at an early stage is the most important determinant of survival; however, the majority of patients are asymptomatic at early stages and the current diagnostic tools used in clinics show limited success in early detection and hence the need for new diagnostic biomarkers. With the advance of techniques in genomic and proteomics, numerous biomarkers are emerging which may serve as a platform for early detection of ovarian cancer. These include gene-, protein-, miRNAs, and m
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Ovarian metastasis"

1

Sieczkiewicz, Gregory J., Mahrukh Hussain, and Elise C. Kohn. "Angiogenesis and Metastasis." In Ovarian Cancer. Springer US, 2002. http://dx.doi.org/10.1007/978-1-4757-3587-1_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Barbolina, Maria V., Natalie M. Moss, Suzanne D. Westfall, et al. "Microenvironmental Regulation of Ovarian Cancer Metastasis." In Cancer Treatment and Research. Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-98094-2_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Cheung, Lydia W. T., Carman K. M. Ip, and Alice S. T. Wong. "Cadherin-Catenin Signaling in Ovarian Cancer Progression." In Signal Transduction in Cancer Metastasis. Springer Netherlands, 2010. http://dx.doi.org/10.1007/978-90-481-9522-0_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ozkacmaz, Sercan. "Radiological Findings of Ovarian Cancer." In The Radiology of Cancer. Nobel Tip Kitabevleri, 2024. http://dx.doi.org/10.69860/nobel.9786053359364.21.

Full text
Abstract:
Detection of ovarian cancer is usually a big challenge as it has not specific symptoms and signs in the earlier stages of the disease. Also most cases are identified in advanced stages because the tumor tends to be spread to the peritoneum in even early phases of the disease. For characterisation and description of the metastasis status of the lesion, the status of size presence of enhancing solid components, vascularised thich septations, vascularised papillary projections, vascularized thick- irregular wall, secondary findings associated with malignant lesions including ascites, omental cake
APA, Harvard, Vancouver, ISO, and other styles
5

Dean, Matthew. "Ex Vivo Ovarian Culture to Model the Initial Metastasis in Ovarian Cancer." In Methods in Molecular Biology. Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1956-8_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Schatten, Heide. "The Impact of Mitochondria in Ovarian Cancer Cell Metabolism, Proliferation, and Metastasis." In Advances in Experimental Medicine and Biology. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-58311-7_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Liu, Jianfei, Shijun Wang, Marius G. Linguraru, and Ronald M. Summers. "Tumor Sensitive Matching Flow: An Approach for Ovarian Cancer Metastasis Detection and Segmentation." In Lecture Notes in Computer Science. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-33612-6_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Freedman, Ralph S., and Chris D. Platsoucas. "Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes." In Cancer Treatment and Research. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-1247-5_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Dolgushin, Mikhail, Valery Kornienko, and Igor Pronin. "Ovarian Cancer." In Brain Metastases. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-57760-9_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kenny, Hilary A., Songuel Dogan, Marion Zillhardt, et al. "Organotypic Models of Metastasis: A Three-dimensional Culture Mimicking the Human Peritoneum and Omentum for the Study of the Early Steps of Ovarian Cancer Metastasis." In Cancer Treatment and Research. Springer US, 2009. http://dx.doi.org/10.1007/978-0-387-98094-2_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Ovarian metastasis"

1

Yan, Yan, Yukun Wang, Yiru Da, and Yongjun Piao. "Single-cell RNA sequencing analysis reveals transcriptional dynamics of immune cells during ovarian cancer metastasis." In 2024 IEEE 9th International Conference on Data Science in Cyberspace (DSC). IEEE, 2024. https://doi.org/10.1109/dsc63484.2024.00115.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Satyaprakash, Mathur Neha, Pratibha Singh, and Suyasha Vyas. "Early stage adenocarcinoma of cervix with ovarian micrometastasis." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685281.

Full text
Abstract:
Introduction: Adenocarcinoma of cervix is a rare malignancy of cervix. It is an aggressive tumour with high incidence of metastasis. Ovarian metastasis in early stage adenocarcinoma is rare. Metastasis is usually seen when there is some other coexisting finding. In premenopausal patient and low risk category, ovarian metastasis is very rare. Case Report: The present case is a 40 yrs old parous women, with complaints of discharge per vaginum. Her colposcopy showed an erosion on the lower lip. Radical hysterectomy with bilateral oophorectomy was planned. The histopathology was a well differentia
APA, Harvard, Vancouver, ISO, and other styles
3

Shah, Swati, Shveta Giri, Rupinder Sekhon, and Sudhir Rawal. "Inguinal lymphadenopathy as a presentation for ovarian cancer." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685329.

Full text
Abstract:
Ovarian carcinoma usually presents at an advanced stage with diffuse intra abdominal manifestations. Inguinal lymph node metastasis is rare event in ovarian cancer. We report 7 cases who presented with inguinal lymphadenopathy as the initial manifestation between January 2014 to January 2016. All patients underwent tru-cut biopsy from inguinal area. Morphology and IHC were suggestive of ovarian origin or female genital Tract origin. Two patients underwent primary debulking surgery while four patients were managed by neo-adjuvant chemotherapy followed by interval cytoreductive surgery owing to
APA, Harvard, Vancouver, ISO, and other styles
4

Xu, Wenwei, Roman Mezencev, Byungkyu Kim, Lijuan Wang, John McDonald, and Todd Sulchek. "Ovarian Cancer Cell Invasiveness Correlates With Increased Cell Deformability." In ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80624.

Full text
Abstract:
Cancer cells undergo a variety of biochemical and biophysical transformations when compared to identical cells displaying a healthy phenotypic state, cancer cells show a drastic reduction of stiffness upon malignancy[1, 2] and change of stiffness of single cells can indicate the presence of disease [3–6]. Besides, metastatic cancer has a higher deformability than their benign counterparts[7, 8]. Using atomic force microscopy, we demonstrated that cancerous ovarian cells (OVCAR3, OVCAR4, HEY and HEYA8) are substantially softer than the healthy immortalized ovarian surface epithelium (IOSE) cell
APA, Harvard, Vancouver, ISO, and other styles
5

Nguyen, Duc Ngoc Hong, David F. Walker, David A. Frank, and Sarah R. Walker. "Abstract 2730: BCL6 promotes ovarian cancer metastasis." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-2730.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Huang, Y. L., C. Y. Liang, D. Ritz та ін. "Integrin α2-collagen interaction promotes ovarian cancer metastasis". У Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). © 2020. Thieme. All rights reserved., 2020. http://dx.doi.org/10.1055/s-0040-1718145.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kim, Kyongjin, KyoungA Kim, SangKi Hong, Jungboom Moon, Taewon Jeong, and Jihyun Kim. "Bone island mimic bone metastasis of ovarian cancer." In KSGO 2023. Korean Society of Gynecologic Oncology, 2023. http://dx.doi.org/10.3802/jgo.2023.34.s1.o11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gellerman, Katrina, Serene Samyesudhas, Stancy Joseph, and Karen Cowden Dahl. "Abstract B41: Investigating ARID3B regulation of ovarian cancer metastasis." In Abstracts: AACR Special Conference on Tumor Invasion and Metastasis - January 20-23, 2013; San Diego, CA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tim2013-b41.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Safra, T., E. Shahar, L. Adar, S. Peleg Hassom, A. Harpaz, and D. Limon. "906 Characteristics of brain metastasis in ovarian cancer patients." In ESGO SoA 2021 Conference Abstracts. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.664.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kim, Jeeyeon, Joo-Hyuk Son, Tae-Wook Kong, Suk-Joon Chang, and Hee-Sug Ryu. "EP239/#800 Prognostic analysis of splenic metastasis in advanced ovarian cancer: does parenchymal metastasis matter?" In IGCS 2022 Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/ijgc-2022-igcs.330.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Ovarian metastasis"

1

Burow, Matthew E. RNA Interference Library Approach to Identifying Mechanisms of Ovarian Cancer Metastasis. Defense Technical Information Center, 2008. http://dx.doi.org/10.21236/ada517354.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Toole, Bryan P. Inhibition of Ovarian Cancer Chemoresistance and Metastasis with Antagonists of Hyaluronan-CD44-CD147 Interactions. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada611022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Toole, Bryan P. Inhibition of Ovarian Cancer Chemoresistance and Metastasis with Antagonists of Hyaluronan-CD44-CD147 Interactions. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada586661.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rinker-Schaeffer, Carrie. Societal Interactions in Ovarian Cancer Metastases: Quorum-Sensing Hypothesis. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada481442.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ruoslahti, Erkki I. New Anti-Metastatic and Anti-Angiogenic Compound for Ovarian Cancer. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ada406191.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rouslahti, Erkki I. New Anti-Metastatic and Anti-Angiogenic Compound for Ovarian Cancer. Defense Technical Information Center, 2003. http://dx.doi.org/10.21236/ada420794.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Rinker-Schaeffer, Carrie W., and Venkat Krishnan. The Role of the Omental Microenvironment in Ovarian Cancer Metastatic Colonization. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada604735.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Yamada, S. D. The Role of MKK4 in the Metastatic Colonization of Ovarian Cancer. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada462588.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rinker-Schaeffer, Carrie W. The Role of the Omental Microenvironment in Ovarian Cancer Metastatic Colonization. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada549601.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Zaraisky, E. I. Efficacy and biosafety of the application of conjugates of monoclonal antibodies to oncoantigen CA125 c 89Zr for visualization of growth of ovarian tumors and their metastases on a mouse model in vivo. Sputnik+, 2018. http://dx.doi.org/10.18411/nts_n9_2018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Ovarian metastasis' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography